The 2020 Technology Showcase welcomed more than 300 viewers for half a day of presentations and panels on technology commercialization and collaboration. The annual event once again highlighted the capabilities of the Frederick National Laboratory for Cancer Research, National Cancer Institute, and greater Frederick region—but this year, with its novel virtual format, it reached new audiences.
The fourth annual Technology Showcase is making a big pivot this year, moving to an entirely virtual event on September 9, 2020. Although the move was made out of necessity, it also offers exciting new opportunities to reach more partners and licensees beyond Frederick, Md.
Frederick has become a key player in biomedical research. That was the clear message from the third annual Technology Showcase, hosted by the National Cancer Institute and the Frederick National Laboratory for Cancer Research. As usual, the event highlighted the numerous technologies developed by NCI and FNL scientists that are available to external groups for licensing and partnership. But this year, it also showcased the strength of the region.
Next month, the annual Technology Showcase will return to the Frederick National Laboratory for Cancer Research. The event attracts research innovators and business professionals who wish to learn about advanced technologies being developed at the National Cancer Institute and Frederick National Laboratory.
Before a crowded auditorium of science and business professionals at the Frederick National Laboratory for Cancer Research’s Advanced Technology Research Facility, Joost Oppenheim, M.D., had just finished his presentation about a compound with the potential to expand the impact of a promising category of cancer therapeutics when he fielded a question from Stephan Stern, Ph.D.
Science and business professionals from across the region will have an opportunity to learn about—and perhaps even commercialize—cutting-edge technologies being used to address some of the most urgent and intractable problems in the biomedical sciences at an upcoming event held at the Frederick National Laboratory for Cancer Research.
By Nancy Parrish, Staff Writer
The Frederick National Laboratory for Cancer Research (FNLCR) recently formed a partnership with the Pancreatic Cancer Action Network (PanCAN) to award a one-year fellowship to two scientists whose research will help lead to new therapies for pancreatic cancer. The scientists will focus on KRAS, a gene in the RAS family that is mutated in 95 percent of pancreatic cancers, according to the National Cancer Institute (NCI).
By Karen Surabian, Thomas Stackhouse, and Jeffrey W. Thomas, Contributing Writers
As the fall and winter seasons progress, you may be attending more scientific conferences, where you may find a number of opportunities for research collaborations.
To assist your lab in reaching its research goals through collaborations, the staff of the National Cancer Institute Technology Transfer Center (NCI TTC) can guide you through a tool box of agreements you may need for protecting your intellectual property (IP) and effectively managing your collaboration.
By Karen Surabian, Thomas Stackhouse, and Jeffrey Thomas, Contributing Writers, and Bruce Crise, Guest Writer
Advancing scientific discovery is increasingly dependent on diverse and innovative partnerships, and the Cooperative Research and Development Agreement (CRADA) is an essential tool for establishing partnerships. CRADAs allow a federal laboratory to enter into collaborative research and development (R&D) projects with outside parties (commercial or nonprofit).
The three-story, 330,000-square-foot Advanced Technology Research Facility has nearly 40,000 square feet designated as partnership space (shown in blue) for co-location of collaborators from industry, academia, nonprofit sectors, and other government agencies. The partnership space, combined with multiple conference rooms and meeting areas, encourages both internal and external collaborations.
